4th Circ. Rips 'Shaky At Best' Drug Price-Fixing Class Action
By Ryan Harroff · February 27, 2025, 4:45 PM EST
The Fourth Circuit backed the dismissal of a proposed class action accusing drug companies of conspiring to inflate the price of a drug for Huntington's disease, writing in the opinion that...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login